Publications

Publications

Filter Results: (136) Arrow Down

Show Results For

← Page 3 of 136 Results →
  • September 2017
  • Supplement

Actera Group: Investing in Mars Cinema Group (A)

By: Victoria Ivashina and Eren Kuzucu
In summer of 2010, Murat Çavuşoğlu (HBS MBA 1994) led private equity firm Actera Group’s investment in Mars Cinema Group (Mars), the leading movie exhibitor in Turkey. Immediately after acquiring Mars and merging it with the second larger player in the market, AFM,... View Details
Keywords: Private Equity; Value Creation; Transformation; Valuation; Entertainment and Recreation Industry; Motion Pictures and Video Industry; Turkey
Related
  • September 2017 (Revised July 2019)
  • Case

Actera Group: Investing in Mars Cinema Group (A)

By: Victoria Ivashina and Eren Kuzucu
In summer of 2010, Murat Çavuşoğlu (HBS MBA 1994) led private equity firm Actera Group’s investment in Mars Cinema Group (Mars), the leading movie exhibitor in Turkey. Immediately after acquiring Mars and merging it with the second largest player in the market, AFM,... View Details
Keywords: Private Equity; Value Creation; Transformation; Valuation; Entertainment and Recreation Industry; Motion Pictures and Video Industry; Turkey
Related
  • 30 Nov 2016
  • Op-Ed

Where Could More Regulation Help Small Businesses? Online Lending.

paperwork, borrowers complete applications in minutes, with approval times cut to days, or even just a few minutes. And, in instances where borrowers want to shop and compare myriad options in one place, they can turn to marketplaces like... View Details
Keywords: by Karen Mills and Brayden McCarthy; Financial Services
  • May 2016
  • Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
Keywords: Pharmaceutical Company; M＆A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Health Industry; United States
Related
  • September 2017
  • Supplement

Actera Group: Investing in Mars Cinema Group (B)

By: Victoria Ivashina and Eren Kuzucu
In summer of 2010, Murat Çavuşoğlu (HBS MBA 1994) led private equity firm Actera Group’s investment in Mars Cinema Group (Mars), the leading movie exhibitor in Turkey. Immediately after acquiring Mars and merging it with the second larger player in the market, AFM,... View Details
Keywords: Private Equity; Value Creation; Transformation; Valuation; Entertainment and Recreation Industry; Motion Pictures and Video Industry; Turkey
Related
  • February 2015
  • Case

Beckman Coulter, 2011

By: John R. Wells and Galen Danskin
In early 2011, Danaher was contemplating the acquisition of Beckman Coulter. With $3.7 billion of revenues in 2010 and $431 million in operating profits, California-based Beckman Coulter was a global leader in blood cell count diagnostic systems and also supplied a... View Details
Keywords: Acquisition; Strategy; Decision Choices and Conditions; Medical Devices and Supplies Industry
Related
  • 05 Jun 2019
  • Research & Ideas

If Your Customers Don't Care What You Charge, What Should You Charge?

shows that when you account for consumer inertia, mergers lead to smaller price increases,” MacKay says. Although using the model MacKay and Remer developed could theoretically result in higher merger approval rates, MacKay says, the... View Details
Keywords: by Kristen Senz; Energy
  • Research Summary

Professor Hiatt’s research is aimed at discovering how institutional factors can affect sector growth and technology development and adoption by mediating and moderating uncertainty. His work encompasses two related research questions:

1) How can... View Details

  • Research Summary

Financial Markets and Corporate Governance

By: Dwight B. Crane
Corporate scandals beginning in the late 1990s focused renewed attention on corporate governance, but significant cracks in the governance system also contributed to recent problems. Deregulation and growth of financial markets, as well as changes in the competitive... View Details
  • 5 Feb 2013
  • Conference Presentation

Financing Entrepreneurial Growth

By: Tom Alberg, Andrew A. Bogan, Harold Bradley, Robert D. Cooter, Monika Gruter Cheney, Oliver R. Goodenough, William R. Hambrecht, Frank Hatheway, Thomas F. Hellmann, Marianne Hudson, Jared Konczal, Josh Lerner, Robert E. Litan, Diane Mulcahy, Ramana Nanda, Frank Partnoy, Joe Ratterman, Nava Ravikant, Jay R. Ritter, Alicia Robb, David T. Robinson, Allison Schrager, Barry Silbert, E. R. Sirri, Daniel Stangler and Sharon Vosmek

Despite recent innovations in entrepreneurial finance, particularly at the early stage of business creation, many new and young companies continue to face hurdles to acquire capital.

The Kauffman Foundation addressed current challenges and opportunities in... View Details

Keywords: Finance; Entrepreneurial Finance; Venture Capital; Entrepreneurship; United States
Related
  • November–December 2015
  • Article

Active Postmarketing Drug Surveillance for Multiple Adverse Events

By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical... View Details
Keywords: Drug Surveillance; Health Care; Stochastic Models; Queueing; Diffusion Approximation; Brownian Motion; Health Care and Treatment; Analytics and Data Science; Analysis
Related
  • 04 Sep 2018
  • First Look

New Research and Ideas, September 4, 2018

financial decision. Telkes must assess the financial merits of the project, as well as understand the regulatory and technological risks associated with going forward or choosing to delay. Purchase this... View Details
Keywords: Dina Gerdeman
  • 09 Apr 2008
  • Research & Ideas

The Matchmaker of the Modern Economy

financial regulatory structures in order to make it viable. Before ARD could offer its stock, for instance, it had to obtain a number of exemptions under the Investment Company Act of 1940 from the Securities and Exchange Commission. ARD... View Details
Keywords: by Spencer E. Ante
  • 25 Apr 2017
  • First Look

First Look at New Research, April 25

special committees can use to level the playing field: for example, contractual commitments from management that allow the board to run the process; pre-signing rather than post-signing market checks; information rights rather than match rights; ex ante inducement... View Details
Keywords: Sean Silverthorne
  • Web

Faculty & Advisors | MBA

public charity in T1D. He is a former director of Provention Bio (NASDAQ: PRVB), which obtained approval for the first disease-modifying therapy in T1D and which has agreed to be acquired by Sanofi. Sean is currently a Fellow in Harvard’s... View Details
  • 12 Jul 2016
  • First Look

July 12, 2016

internalize the social costs of higher leverage in the form of greater bankruptcy losses (moral hazard) and are subject to a regulatory capital requirement. In contrast, shadow bank liabilities are subject to runs and credit risk and thus... View Details
Keywords: Sean Silverthorne
  • Fall 2020
  • Article

Christo and Jeanne‐Claude: The Negotiation of Art and Vice Versa

By: Michael A. Wheeler
Over the past two decades the Program on Negotiation at Harvard Law School (PON) has named thirteen people as Great Negotiators. The project, directed by my colleague Jim Sebenius, has given us the opportunity to commend our honorees’ outstanding work and to learn from... View Details
Keywords: Art; Negotiation; Arts
Related
  • 02 Nov 2016
  • HBS Seminar

Gillian Hadfield, University of California, Gould School of Law

  • 07 Jul 2008
  • Research & Ideas

Innovation Corrupted: How Managers Can Avoid Another Enron

regulatory agencies, and the absence of Enron's ethical discipline while choosing to live in the murky borderlands of the law." Our Q&A follows. Martha Lagace: In a nutshell, why did Enron succeed insofar as it did? How did it... View Details
Keywords: by Martha Lagace; Energy; Utilities
  • 10 Aug 2010
  • First Look

First Look: August 10

organizations that adopt it within a highly scrutinized regulatory environment but absent in a direct regulatory threat. The Quest for the 'Holy Grail' of Integrated Financial and CSR Reporting... View Details
Keywords: Martha Lagace